|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.38 CNY | +2.13% |
|
-0.35% | -4.58% |
| 07:52am | Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-16 | Tasly Subsidiary Gets China Approval for Hypertension Drug | MT |
| Market Cap | 21.48B 3.17B 2.78B 2.57B 2.37B 4.48B 303B 4.57B 30.68B 12.03B 149B 11.9B 11.64B 514B | P/E 2026 * |
16.2x | P/E 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 19.23B 2.84B 2.49B 2.3B 2.12B 4.01B 271B 4.09B 27.45B 10.77B 133B 10.65B 10.41B 460B | EV / Sales 2026 * |
2.14x | EV / Sales 2027 * | 1.92x |
| Free-Float |
47.15% | Yield 2026 * |
2.79% | Yield 2027 * | 3.5% |
| 1 day | +2.13% | ||
| 1 week | -0.35% | ||
| Current month | +8.69% | ||
| 1 month | -0.21% | ||
| 3 months | +3.68% | ||
| 6 months | -6.38% | ||
| Current year | -4.58% |
| 1 week | 13.78 |  | 14.49 |
| 1 month | 12.9 | | 14.6 |
| Current year | 12.9 | | 15.49 |
| 1 year | 12.9 | | 17.69 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 2024-05-07 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 2018-07-08 |
Xin Yang
CIO | Chief Investment Officer | 45 | 2025-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiao Meng Jiang
BRD | Director/Board Member | 62 | 2007-08-16 |
Ai Jian Wang
BRD | Director/Board Member | 72 | 2021-06-01 |
Jin Yong Cai
BRD | Director/Board Member | 54 | 2006-03-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.13% | -0.35% | -9.27% | +5.50% | 3.17B | |
| +1.90% | +0.95% | -11.27% | -8.51% | 13.09B | |
| +3.59% | +3.46% | -31.29% | -52.96% | 4.96B | |
| +4.15% | +2.50% | -3.60% | -5.18% | 4.59B | |
| +6.19% | +4.24% | +10.39% | -34.17% | 4.06B | |
| +3.72% | -4.14% | +15.82% | -5.13% | 3.8B | |
| +2.71% | +5.53% | -6.14% | -8.99% | 3.35B | |
| +1.03% | +0.64% | -7.29% | -22.06% | 2.43B | |
| +4.33% | +6.34% | -1.05% | +50.87% | 1.88B | |
| +3.44% | +0.14% | -7.46% | -12.24% | 1.73B | |
| Average | +3.32% | +3.86% | -5.12% | -9.29% | 4.31B | |
| Weighted average by Cap. | +3.10% | +3.56% | -6.96% | -12.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9B 1.33B 1.16B 1.08B 992M 1.88B 127B 1.91B 12.84B 5.04B 62.35B 4.98B 4.87B 215B | 9.87B 1.46B 1.28B 1.18B 1.09B 2.06B 139B 2.1B 14.09B 5.53B 68.42B 5.47B 5.35B 236B |
| Net income | 1.33B 196M 172M 159M 146M 277M 18.73B 282M 1.89B 743M 9.2B 735M 719M 31.77B | 1.59B 234M 205M 190M 175M 331M 22.39B 337M 2.27B 888M 11B 878M 859M 37.97B |
| Net Debt | -2.26B -333M -292M -270M -249M -471M -31.87B -480M -3.22B -1.26B -15.65B -1.25B -1.22B -54.05B | -2.58B -380M -333M -309M -284M -537M -36.35B -547M -3.68B -1.44B -17.85B -1.43B -1.39B -61.65B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-13 | CN¥14.38 | +2.13% | 21,133,055 |
| 26-07-10 | CN¥14.08 | +0.28% | 11,098,404 |
| 26-07-09 | CN¥14.04 | -0.14% | 8,362,286 |
| 26-07-08 | CN¥14.06 | +0.21% | 8,193,060 |
| 26-07-07 | CN¥14.03 | -2.77% | 11,300,968 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
